U 84935 → HCID 70059045, compound
Reaction equation
[CH:1]1([C:4]2[O:8][N:7]=[C:6]([C:9]3[N:10]=[CH:11][N:12]4[C:21]5[CH:20]=[CH:19][CH:18]=[CH:17][C:16]=5[C:15]5=[N:22][CH2:23][CH2:24][N:14]5[C:13]=34)[N:5]=2)[CH2:3][CH2:2]1.[C:25]([OH:34])(=[O:33])[C@@H:26]([C@H:28]([C:30]([OH:32])=[O:31])[OH:29])[OH:27]>ClCCl>[C:30]([C@@H:28]([C@H:26]([C:25]([OH:34])=[O:33])[OH:27])[OH:29])([OH:32])=[O:31].[CH:1]1([C:4]2[O:8][N:7]=[C:6]([C:9]3[N:10]=[CH:11][N:12]4[C:21]5[CH:20]=[CH:19][CH:18]=[CH:17][C:16]=5[C:15]5=[N:22][CH2:23][CH2:24][N:14]5[C:13]=34)[N:5]=2)[CH2:3][CH2:2]1Participants
4
Reagents, catalysts & solvents 1
Procedure
Equimolar amounts of 5-(5-cyclopropyl-1,2,4-oxadiazol-3-yl)-2,3-dihydrodiimidazo[1,5-a:1',2'-c]quinazoline (0.64 g) and L-tartaric acid (0.30 g) was stirred in dichloromethane (25 ml) until a clear solution was obtained. The solvent was removed by evaporation in vacuo and the residue was triturated with isopropyl alcohol. The crystalline precipitate was filtered off and recrystallized from ethanol yielding the title compound as pale crystals, m.p. 160°-163° C. (Compound 41).
Workup
- customwas obtained
- customThe solvent was removed by evaporation in vacuo
- customthe residue was triturated with isopropyl alcohol
- filtrationThe crystalline precipitate was filtered off
- customrecrystallized from ethanol yielding the title compound as pale crystals, m.p. 160°-163° C. (Compound 41)
Sources & evidence
- ORD record
- ord-3ff57096c9694f3d9418f2558d2626f8
- Source dataset
- uspto-grants-1992_03
- Patent number
- US05100895
Reaction notes
Loading…